falsefalse

My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early Relapse - Episode 6

Treatment of Patients With MM and High-Risk Cytogenetics

,

Dr Brea Lipe explains at what stages she orders genetic testing in patients with relapsed/refractory multiple myeloma and how she approaches the treatment of patients with high-risk cytogenetics.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma
    EP. 2: Treatment Options for Patients with Multiple Myeloma in Early Relapse
    EP. 3: IKEMA Trial of Isatuximab plus Carfilzomib and Dexamethasone in R/R MM
    EP. 4: Clinical Implications of the IKEMA Trial in R/R MM
    EP. 5: Selecting the Appropriate Patients With MM for Treatment With Isa-Kd
    Now Viewing
    EP. 6: Treatment of Patients With MM and High-Risk Cytogenetics
    EP. 7: Patient Profile 2: A 76-Year-Old Female with R/R MM
    EP. 8: CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM
    EP. 9: Selecting Patients for Treatment With DARA-Kd
    EP. 10: Sequencing Therapies in Patients With R/R MM
    EP. 11: Advice for Community Oncologists Treating Patients With R/R MM

    Related Content:

    My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early RelapseMultiple MyelomaInsights
    Sequencing the Available T Cell– Engaging Therapies, and the Role of Bridging/Holding Therapy in RRMM
    Exploring the Treatment Options for RRMM
    Navigating Early-Line Treatment Options for HER2+ Metastatic Breast Cancer
    x